| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |